To determine whether a similar pathway of mTOR and IL-15 suppression may explain the reduced DETC homeostasis in the STZ diabetes model, we examined the effects of diabetes induction over a timecourse of STZ treatment. This evidence concerns the gene MTOR and diabetes mellitus.